Drug Shortage Report for SANDOZ QUETIAPINE
Report ID | 123421 |
Drug Identification Number | 02314002 |
Brand name | SANDOZ QUETIAPINE |
Common or Proper name | SANDOZ QUETIAPINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 FCT BO V1 CA |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-08-28 |
Estimated end date | Unknown |
Actual end date | 2021-02-28 |
Shortage status | Resolved |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-08-31 | English | Compare |
v2 | 2020-08-31 | French | Compare |
v3 | 2023-11-17 | English | Compare |
v4 | 2023-11-17 | French | Compare |
Showing 1 to 4 of 4